Inactive Instrument

Other languages VitaSpring Biomedical Co. Ltd. Other OTC

Equities

VSBC

US92851B1026

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

VITASPRING BIOMEDICAL CO. LTD. : Changes in Registrant's Certifying Accountant (form 8-K)	27/01/23
VITASPRING BIOMEDICAL CO. LTD. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	21/12/22
VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2022	21/12/22
VITASPRING BIOMEDICAL CO. LTD. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	15/09/22
VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2022	15/09/22
VITASPRING BIOMEDICAL CO. LTD. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	15/06/22
VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the First Quarter Ended April 30, 2022	15/06/22
VITASPRING BIOMEDICAL CO. LTD. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	03/05/22
VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Full Year Ended January 31, 2022	03/05/22
VitaSpring Biomedical Co. Ltd. Auditor Raises 'Going Concern' Doubt	02/05/22
VITASPRING BIOMEDICAL CO. LTD. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	23/12/21
VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2021	23/12/21
QuantuMDx Group Limited announced that it has received ?15 million in funding from VitaSpring Biomedical Co. Ltd.	06/11/21
VITASPRING BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	15/09/21
Vitaspring Biomedical Co. Ltd. Reports Earnings Results for the Second Quarter Ended July 31, 2021	15/09/21
VITASPRING BIOMEDICAL CO. LTD. : Change in Directors or Principal Officers (form 8-K)	11/08/21
Vitaspring Biomedical Co. Ltd. Announces Management Changes	11/08/21
VITASPRING BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	14/06/21
Vitaspring Biomedical Co. Ltd. Reports Earnings Results for the First Quarter Ended April 30, 2021	14/06/21
VITASPRING BIOMEDICAL CO. LTD. : Unregistered Sale of Equity Securities (form 8-K)	22/04/21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages VitaSpring Biomedical Co. Ltd. Other OTC

Equities

VSBC

US92851B1026

Other languages

Filters